{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:01:14Z","timestamp":1792515674861,"version":"4.5.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Our understanding of the oncogenesis of high-grade serous cancer of the ovary and its precursor lesions, such as serous tubal intraepithelial carcinoma (STIC), has significantly increased over the last decades. Adequate and reproducible diagnosis of these precursor lesions is important. Diagnosing STIC can have prognostic consequences and is an absolute requirement for safely offering alternative risk reducing strategies, such as risk reducing salpingectomy with delayed oophorectomy. However, diagnosing STIC is a challenging task, possessing only moderate reproducibility. In this review and meta-analysis, we look at how pathologists come to a diagnosis of STIC. We performed a literature search identifying 39 studies on risk reducing salpingo-oophorectomy in women with a known BRCA1\/2 PV, collectively reporting on 6833 patients. We found a pooled estimated proportion of STIC of 2.8% (95% CI, 2.0\u20133.7). We focused on reported grossing protocols, morphological criteria, level of pathologist training, and the use of immunohistochemistry. The most commonly mentioned morphological characteristics of STIC are (1) loss of cell polarity, (2) nuclear pleomorphism, (3) high nuclear to cytoplasmic ratio, (4) mitotic activity, (5) pseudostratification, and (6) prominent nucleoli. The difference in reported incidence of STIC between studies who totally embedded all specimens and those who did not was 3.2% (95% CI, 2.3\u20134.2) versus 1.7% (95% CI, 0.0\u20136.2) (<jats:italic>p<\/jats:italic> 0.24). We provide an overview of diagnostic features and present a framework for arriving at an adequate diagnosis, consisting of the use of the SEE-FIM grossing protocol, evaluation by a subspecialized gynecopathologist, rational use of immunohistochemical staining, and obtaining a second opinion from a colleague.<\/jats:p>","DOI":"10.1007\/s00428-021-03244-w","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T02:02:52Z","timestamp":1638324172000},"page":"725-737","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Recommendations for diagnosing STIC: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"480","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0772-6712","authenticated-orcid":false,"given":"Joep M. A.","family":"Bogaerts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda P.","family":"Steenbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majke H. D.","family":"van Bommel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Bulten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen A. W. M.","family":"van der Laak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne A.","family":"de Hullu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel","family":"Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,1]]},"reference":[{"key":"3244_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/01.pgp.0000101080.35393.16","volume":"23","author":"JD Seidman","year":"2004","unstructured":"Seidman JD, Horkayne-Szakaly I, Haiba M et al (2004) The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin. Int J Gynecol Pathol 23:41\u201344","journal-title":"Int J Gynecol Pathol"},{"key":"3244_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/jnci\/djy071","volume":"111","author":"LC Peres","year":"2019","unstructured":"Peres LC, Cushing-Haugen KL, K\u00f6bel M et al (2019) Invasive epithelial ovarian cancer survival by histotype and disease stage. J Natl Cancer Inst 111:60. https:\/\/doi.org\/10.1093\/jnci\/djy071","journal-title":"J Natl Cancer Inst"},{"key":"3244_CR3","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1016\/s0140-6736(21)00731-5","volume":"397","author":"U Menon","year":"2021","unstructured":"Menon U, Gentry-Maharaj A, Burnell M et al (2021) Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet 397:2182\u20132193. https:\/\/doi.org\/10.1016\/s0140-6736(21)00731-5","journal-title":"Lancet"},{"key":"3244_CR4","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR et al (2017) Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA - J Am Med Assoc 317:2402\u20132416. https:\/\/doi.org\/10.1001\/jama.2017.7112","journal-title":"JAMA - J Am Med Assoc"},{"key":"3244_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1001\/jama.296.2.185","volume":"296","author":"SA Narod","year":"2006","unstructured":"Narod SA (2006) Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation. J Am Med Assoc 296:185\u2013192. https:\/\/doi.org\/10.1001\/jama.296.2.185","journal-title":"J Am Med Assoc"},{"key":"3244_CR6","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1080\/13697137.2017.1285879","volume":"20","author":"RFM Vermeulen","year":"2017","unstructured":"Vermeulen RFM, van Beurden M, Korse CM, Kenter GG (2017) Impact of risk-reducing salpingo-oophorectomy in premenopausal women. Climacteric 20:212\u2013221. https:\/\/doi.org\/10.1080\/13697137.2017.1285879","journal-title":"Climacteric"},{"key":"3244_CR7","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/path.3023","volume":"226","author":"E Kuhn","year":"2012","unstructured":"Kuhn E, Kurman RJ, Vang R et al (2012) TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma-evidence supporting the clonal relationship of the two lesions. J Pathol 226:421\u2013426. https:\/\/doi.org\/10.1002\/path.3023","journal-title":"J Pathol"},{"key":"3244_CR8","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1097\/PAS.0b013e3181dcede7","volume":"34","author":"E Kuhn","year":"2010","unstructured":"Kuhn E, Meeker A, Wang TL et al (2010) Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis. Am J Surg Pathol 34:829\u2013836. https:\/\/doi.org\/10.1097\/PAS.0b013e3181dcede7","journal-title":"Am J Surg Pathol"},{"key":"3244_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1365-2559.2007.02938.x","volume":"53","author":"EA Jarboe","year":"2008","unstructured":"Jarboe EA, Folkins AK, Drapkin R et al (2008) Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective. Histopathology 53:127\u2013138","journal-title":"Histopathology"},{"key":"3244_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12885-015-1597-Y","volume":"15","author":"MG Harmsen","year":"2015","unstructured":"Harmsen MG, Arts-de Jong M, Hoogerbrugge N et al (2015) Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1\/2 mutation carriers (TUBA study): A prospective non-randomised multicentre study. BMC Cancer 15:1\u20139. https:\/\/doi.org\/10.1186\/S12885-015-1597-Y","journal-title":"BMC Cancer"},{"key":"3244_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/J.YGYNO.2017.05.034","volume":"146","author":"SE Dilley","year":"2017","unstructured":"Dilley SE, Havrilesky LJ, Bakkum-Gamez J et al (2017) Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention. Gynecol Oncol 146:373\u2013379. https:\/\/doi.org\/10.1016\/J.YGYNO.2017.05.034","journal-title":"Gynecol Oncol"},{"key":"3244_CR12","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/BJS.11419","volume":"107","author":"G Tomasch","year":"2020","unstructured":"Tomasch G, Lemmerer M, Oswald S et al (2020) Prophylactic salpingectomy for prevention of ovarian cancer at the time of elective laparoscopic cholecystectomy. Br J Surg 107:519\u2013524. https:\/\/doi.org\/10.1002\/BJS.11419","journal-title":"Br J Surg"},{"key":"3244_CR13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/J.EJOGRB.2018.03.043","volume":"225","author":"A Ntoumanoglou-Schuiki","year":"2018","unstructured":"Ntoumanoglou-Schuiki A, Tomasch G, Laky R et al (2018) Opportunistic prophylactic salpingectomy for prevention of ovarian cancer: what do national societies advise? Eur J Obstet Gynecol Reprod Biol 225:110\u2013112. https:\/\/doi.org\/10.1016\/J.EJOGRB.2018.03.043","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"3244_CR14","doi-asserted-by":"publisher","unstructured":"Samimi G, Trabert B, Geczik AM et al (2018) Population Frequency of Serous Tubal Intraepithelial Carcinoma (STIC) in Clinical Practice Using SEE-Fim Protocol. JNCI Cancer Spectr 2. https:\/\/doi.org\/10.1093\/JNCICS\/PKY061","DOI":"10.1093\/JNCICS\/PKY061"},{"key":"3244_CR15","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1111\/1471-0528.14543","volume":"124","author":"F Chen","year":"2017","unstructured":"Chen F, Gaitskell K, Garcia MJ et al (2017) Serous tubal intraepithelial carcinomas associated with high-grade serous ovarian carcinomas: a systematic review. BJOG An Int J Obstet Gynaecol 124:872\u2013878","journal-title":"BJOG An Int J Obstet Gynaecol"},{"key":"3244_CR16","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.ygyno.2018.11.033","volume":"152","author":"TR Soong","year":"2019","unstructured":"Soong TR, Howitt BE, Horowitz N et al (2019) The fallopian tube, \u201cprecursor escape\u201d and narrowing the knowledge gap to the origins of high-grade serous carcinoma. Gynecol Oncol 152:426\u2013433","journal-title":"Gynecol Oncol"},{"key":"3244_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13048-019-0525-1","volume":"12","author":"PI Stanciu","year":"2019","unstructured":"Stanciu PI, Ind TEJ, Barton DPJ et al (2019) Development of Peritoneal Carcinoma in women diagnosed with Serous Tubal Intraepithelial Carcinoma (STIC) following Risk-Reducing Salpingo-Oophorectomy (RRSO). J Ovarian Res 12:1\u20136. https:\/\/doi.org\/10.1186\/S13048-019-0525-1","journal-title":"J Ovarian Res"},{"key":"3244_CR18","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1136\/ijgc-2019-000308","volume":"29","author":"N Colombo","year":"2019","unstructured":"Colombo N, Sessa C, Du BA et al (2019) ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease. Int J Gynecol Cancer 29:728\u2013760. https:\/\/doi.org\/10.1136\/ijgc-2019-000308","journal-title":"Int J Gynecol Cancer"},{"key":"3244_CR19","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","volume":"30","author":"F Medeiros","year":"2006","unstructured":"Medeiros F, Muto MG, Lee Y et al (2006) The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol 30:230\u2013236. https:\/\/doi.org\/10.1097\/01.pas.0000180854.28831.77","journal-title":"Am J Surg Pathol"},{"key":"3244_CR20","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.ygyno.2014.07.084","volume":"134","author":"I Cass","year":"2014","unstructured":"Cass I, Walts AE, Barbuto D et al (2014) A cautious view of putative precursors of serous carcinomas in the fallopian tubes of BRCA mutation carriers. Gynecol Oncol 134:492\u2013497. https:\/\/doi.org\/10.1016\/j.ygyno.2014.07.084","journal-title":"Gynecol Oncol"},{"key":"3244_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/01.pgp.0000101082.35393.84","volume":"23","author":"ML Carcangiu","year":"2004","unstructured":"Carcangiu ML, Radice P, Manoukian S et al (2004) Atypical epithelial proliferation in fallopian tubes in prophylactic salpingo-oophorectomy specimens from BRCA1 and BRCA2 germline mutation carriers. Int J Gynecol Pathol 23:35\u201340. https:\/\/doi.org\/10.1097\/01.pgp.0000101082.35393.84","journal-title":"Int J Gynecol Pathol"},{"key":"3244_CR22","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1097\/01.pas.0000202161.80739.ac","volume":"30","author":"ML Carcangiu","year":"2006","unstructured":"Carcangiu ML, Peissel B, Pasini B et al (2006) Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature. Am J Surg Pathol 30:1222\u20131230","journal-title":"Am J Surg Pathol"},{"key":"3244_CR23","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1016\/j.ajog.2006.03.006","volume":"194","author":"JD Lamb","year":"2006","unstructured":"Lamb JD, Garcia RL, Goff BA et al (2006) Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy. Am J Obstet Gynecol 194:1702\u20131709. https:\/\/doi.org\/10.1016\/j.ajog.2006.03.006","journal-title":"Am J Obstet Gynecol"},{"key":"3244_CR24","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/IGC.0b013e3181a1b5dc","volume":"19","author":"JE Hirst","year":"2009","unstructured":"Hirst JE, Gard GB, Mcillroy K et al (2009) High rates of occult fallopian tube cancer diagnosed at prophylactic bilateral salpingo-oophorectomy. Int J Gynecol Cancer 19:826\u2013829. https:\/\/doi.org\/10.1111\/IGC.0b013e3181a1b5dc","journal-title":"Int J Gynecol Cancer"},{"key":"3244_CR25","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1097\/PAS.0b013e3181bc6059","volume":"33","author":"JT Rabban","year":"2009","unstructured":"Rabban JT, Krasik E, Chen LM et al (2009) Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: Implications for defining an optimal specimen dissection protocol. Am J Surg Pathol 33:1878\u20131885. https:\/\/doi.org\/10.1097\/PAS.0b013e3181bc6059","journal-title":"Am J Surg Pathol"},{"key":"3244_CR26","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/modpathol.2009.89","volume":"22","author":"PA Shaw","year":"2009","unstructured":"Shaw PA, Rouzbahman M, Pizer ES et al (2009) Candidate serous cancer precursors in fallopian tube epithelium of BRCA1\/2 mutation carriers. Mod Pathol 22:1133\u20131138. https:\/\/doi.org\/10.1038\/modpathol.2009.89","journal-title":"Mod Pathol"},{"key":"3244_CR27","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/PGP.0b013e318216d447","volume":"30","author":"K Leonhardt","year":"2011","unstructured":"Leonhardt K, Einenkel J, Sohr S et al (2011) P53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary. Int J Gynecol Pathol 30:417\u2013424. https:\/\/doi.org\/10.1097\/PGP.0b013e318216d447","journal-title":"Int J Gynecol Pathol"},{"key":"3244_CR28","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1111\/j.1471-0528.2011.02920.x","volume":"118","author":"R Manchanda","year":"2011","unstructured":"Manchanda R, Abdelraheim A, Johnson M et al (2011) Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status. BJOG An Int J Obstet Gynaecol 118:814\u2013824. https:\/\/doi.org\/10.1111\/j.1471-0528.2011.02920.x","journal-title":"BJOG An Int J Obstet Gynaecol"},{"key":"3244_CR29","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1097\/IGC.0b013e31821bc7e3","volume":"21","author":"CB Powell","year":"2011","unstructured":"Powell CB, Chen LM, McLennan J et al (2011) Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol. Int J Gynecol Cancer 21:846\u2013851. https:\/\/doi.org\/10.1097\/IGC.0b013e31821bc7e3","journal-title":"Int J Gynecol Cancer"},{"key":"3244_CR30","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1097\/IGC.0b013e318257b936","volume":"22","author":"OM Bacha","year":"2012","unstructured":"Bacha OM, Gregoire J, Grondin K et al (2012) Effectiveness of risk-reducing salpingo-oophorectomy in preventing ovarian cancer in a high-risk French Canadian population. Int J Gynecol Cancer 22:974\u2013978. https:\/\/doi.org\/10.1097\/IGC.0b013e318257b936","journal-title":"Int J Gynecol Cancer"},{"key":"3244_CR31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ygyno.2012.06.015","volume":"127","author":"MJJM Mingels","year":"2012","unstructured":"Mingels MJJM, Roelofsen T, Van Der Laak JAWM et al (2012) Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls. Gynecol Oncol 127:88\u201393. https:\/\/doi.org\/10.1016\/j.ygyno.2012.06.015","journal-title":"Gynecol Oncol"},{"key":"3244_CR32","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ygyno.2013.01.029","volume":"129","author":"CB Powell","year":"2013","unstructured":"Powell CB, Swisher EM, Cass I et al (2013) Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy. Gynecol Oncol 129:364\u2013371. https:\/\/doi.org\/10.1016\/j.ygyno.2013.01.029","journal-title":"Gynecol Oncol"},{"key":"3244_CR33","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejca.2012.07.021","volume":"49","author":"W Reitsma","year":"2013","unstructured":"Reitsma W, De Bock GH, Oosterwijk JC et al (2013) Support of the \u201cfallopian tube hypothesis\u201d in a prospective series of risk-reducing salpingo-oophorectomy specimens. Eur J Cancer 49:132\u2013141. https:\/\/doi.org\/10.1016\/j.ejca.2012.07.021","journal-title":"Eur J Cancer"},{"key":"3244_CR34","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1097\/IGC.0b013e3182a80ac8","volume":"23","author":"SL Wethington","year":"2013","unstructured":"Wethington SL, Park KJ, Soslow RA et al (2013) Clinical outcome of isolated Serous tubal intraepithelial carcinomas (STIC). Int J Gynecol Cancer 23:1603\u20131611. https:\/\/doi.org\/10.1097\/IGC.0b013e3182a80ac8","journal-title":"Int J Gynecol Cancer"},{"key":"3244_CR35","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.ygyno.2013.12.009","volume":"132","author":"JR Conner","year":"2014","unstructured":"Conner JR, Meserve E, Pizer E et al (2014) Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations. Gynecol Oncol 132:280\u2013286. https:\/\/doi.org\/10.1016\/j.ygyno.2013.12.009","journal-title":"Gynecol Oncol"},{"key":"3244_CR36","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1200\/JCO.2013.54.1987","volume":"32","author":"ME Sherman","year":"2014","unstructured":"Sherman ME, Piedmonte M, Mai PL et al (2014) Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group trial GOG-0199. J Clin Oncol 32:3275\u20133283. https:\/\/doi.org\/10.1200\/JCO.2013.54.1987","journal-title":"J Clin Oncol"},{"key":"3244_CR37","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s00428-016-1928-7","volume":"468","author":"K Malmberg","year":"2016","unstructured":"Malmberg K, Klynning C, Fl\u00f6ter-R\u00e5destad A, Carlson JW (2016) Serous tubal intraepithelial carcinoma, chronic fallopian tube injury, and serous carcinoma development. Virchows Arch 468:707\u2013713. https:\/\/doi.org\/10.1007\/s00428-016-1928-7","journal-title":"Virchows Arch"},{"key":"3244_CR38","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1097\/IGC.0000000000000791","volume":"26","author":"C Poon","year":"2016","unstructured":"Poon C, Hyde S, Grant P et al (2016) Incidence and Characteristics of Unsuspected Neoplasia Discovered in High-Risk Women Undergoing Risk Reductive Bilateral Salpingooophorectomy. Int J Gynecol Cancer 26:1415\u20131420. https:\/\/doi.org\/10.1097\/IGC.0000000000000791","journal-title":"Int J Gynecol Cancer"},{"key":"3244_CR39","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ygyno.2016.08.336","volume":"143","author":"M Zakhour","year":"2016","unstructured":"Zakhour M, Danovitch Y, Lester J et al (2016) Occult and subsequent cancer incidence following risk-reducing surgery in BRCA mutation carriers. Gynecol Oncol 143:231\u2013235. https:\/\/doi.org\/10.1016\/j.ygyno.2016.08.336","journal-title":"Gynecol Oncol"},{"key":"3244_CR40","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1097\/IGC.0000000000000954","volume":"27","author":"C Ayres","year":"2017","unstructured":"Ayres C, Ratnayake G, McNally O, Quinn M (2017) Challenging salpingectomy as a risk-reducing measure for ovarian cancer: histopathological analysis of the tubo-ovarian interface in women undergoing risk-reducing salpingo-oophorectomy. Int J Gynecol Cancer 27:703\u2013707. https:\/\/doi.org\/10.1097\/IGC.0000000000000954","journal-title":"Int J Gynecol Cancer"},{"key":"3244_CR41","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.jmig.2017.04.017","volume":"24","author":"G Bogani","year":"2017","unstructured":"Bogani G, Tagliabue E, Signorelli M et al (2017) Assessing the risk of occult cancer and 30-day morbidity in women undergoing risk-reducing surgery: a prospective experience. J Minim Invasive Gynecol 24:837\u2013842. https:\/\/doi.org\/10.1016\/j.jmig.2017.04.017","journal-title":"J Minim Invasive Gynecol"},{"key":"3244_CR42","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s10689-017-9977-x","volume":"16","author":"YC Lee","year":"2017","unstructured":"Lee YC, Bressel M, Grant P et al (2017) Improved quality of risk-reducing salpingo-oophorectomy in Australasian women at high risk of pelvic serous cancer. Fam Cancer 16:461\u2013469. https:\/\/doi.org\/10.1007\/s10689-017-9977-x","journal-title":"Fam Cancer"},{"key":"3244_CR43","doi-asserted-by":"publisher","unstructured":"Lee YJ, Lee SW, Kim KR et al (2017) Pathologic findings at risk-reducing salpingo-oophorectomy (RRSO) in germline BRCA mutation carriers with breast cancer: significance of bilateral RRSO at the optimal age in germline BRCA mutation carriers. J Gynecol Oncol 28. https:\/\/doi.org\/10.3802\/JGO.2017.28.E3","DOI":"10.3802\/JGO.2017.28.E3"},{"key":"3244_CR44","doi-asserted-by":"publisher","first-page":"5241","DOI":"10.21873\/anticanres.11948","volume":"37","author":"E Ricciardi","year":"2017","unstructured":"Ricciardi E, Tomao F, Aletti G et al (2017) Risk-reducing salpingo-oophorectomy in women at higher risk of ovarian and breast cancer: a single institution prospective series. Anticancer Res. 37:5241\u20135248. https:\/\/doi.org\/10.21873\/anticanres.11948","journal-title":"Anticancer Res."},{"key":"3244_CR45","first-page":"381","volume":"39","author":"G Artioli","year":"2018","unstructured":"Artioli G, Wabersich J, Borgato L, Azzarello G (2018) Why tube fimbria-end is the favorite site of carcinogenesis in hereditary ovarian cancer? A review of literature and our institution experience. Eur J Gynaecol Oncol 39:381\u2013385","journal-title":"Eur J Gynaecol Oncol"},{"key":"3244_CR46","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s12094-018-1865-9","volume":"20","author":"L Minig","year":"2018","unstructured":"Minig L, Cabrera S, Oliver R et al (2018) Pathology findings and clinical outcomes after risk reduction salpingo-oophorectomy in BRCA mutation carriers: a multicenter Spanish study. Clin Transl Oncol 20:1337\u20131344. https:\/\/doi.org\/10.1007\/s12094-018-1865-9","journal-title":"Clin Transl Oncol"},{"key":"3244_CR47","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s11845-017-1717-6","volume":"187","author":"C Thompson","year":"2018","unstructured":"Thompson C, McCormick C, Kamran W et al (2018) Risk reduction surgery (RRS) for tubo-ovarian cancer in an Irish gynaecological practice: an analysis of indications and outcomes. Ir J Med Sci 187:789\u2013794. https:\/\/doi.org\/10.1007\/s11845-017-1717-6","journal-title":"Ir J Med Sci"},{"key":"3244_CR48","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.clon.2018.03.036","volume":"30","author":"NMA Van der Hoeven","year":"2018","unstructured":"Van der Hoeven NMA, Van Wijk K, Bonfrer SE et al (2018) Outcome and prognostic impact of surgical staging in serous tubal intraepithelial carcinoma: a cohort study and systematic review. Clin Oncol 30:463\u2013471. https:\/\/doi.org\/10.1016\/j.clon.2018.03.036","journal-title":"Clin Oncol"},{"key":"3244_CR49","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1158\/1940-6207.CAPR-18-0009","volume":"11","author":"K Visvanathan","year":"2018","unstructured":"Visvanathan K, Shaw P, May BJ et al (2018) Fallopian tube lesions in women at high risk for ovarian cancer: a multicenter study. Cancer Prev Res 11:697\u2013705. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-18-0009","journal-title":"Cancer Prev Res"},{"key":"3244_CR50","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/his.13503","volume":"73","author":"S Wong","year":"2018","unstructured":"Wong S, Ratner E, Buza N (2018) Intra-operative evaluation of prophylactic hysterectomy and salpingo-oophorectomy specimens in hereditary gynaecological cancer syndromes. Histopathology 73:109\u2013123. https:\/\/doi.org\/10.1111\/his.13503","journal-title":"Histopathology"},{"key":"3244_CR51","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ygyno.2019.03.003","volume":"153","author":"F Blok","year":"2019","unstructured":"Blok F, Dasgupta S, Dinjens WNM et al (2019) Retrospective study of a 16 year cohort of BRCA1 and BRCA2 carriers presenting for RRSO: prevalence of invasive and in-situ carcinoma, with follow-up. Gynecol Oncol 153:326\u2013334. https:\/\/doi.org\/10.1016\/j.ygyno.2019.03.003","journal-title":"Gynecol Oncol"},{"key":"3244_CR52","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ejogrb.2020.01.040","volume":"247","author":"V Rudaitis","year":"2020","unstructured":"Rudaitis V, Mikliusas V, Januska G et al (2020) The incidence of occult ovarian neoplasia and cancer in BRCA1\/2 mutation carriers after the bilateral prophylactic salpingo-oophorectomy (PBSO): a single-center prospective study. Eur J Obstet Gynecol Reprod Biol 247:26\u201331. https:\/\/doi.org\/10.1016\/j.ejogrb.2020.01.040","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"3244_CR53","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.gore.2019.01.010","volume":"28","author":"ME Stewart","year":"2019","unstructured":"Stewart ME, Knisely AT, Sullivan MW et al (2019) Evaluation of screening and risk-reducing surgery for women followed in a high-risk breast\/ovarian cancer clinic: it is all about the tubes in BRCA mutation carriers. Gynecol Oncol Rep 28:18\u201322. https:\/\/doi.org\/10.1016\/j.gore.2019.01.010","journal-title":"Gynecol Oncol Rep"},{"key":"3244_CR54","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1097\/AOG.0000000000003421","volume":"134","author":"AM Wilhite","year":"2019","unstructured":"Wilhite AM, Oestreich MC, Olson M et al (2019) Health Care Provider Adherence to Surgical Guidelines for Risk-Reducing Salpingo-Oophorectomy. Obstet Gynecol 134:520\u2013526. https:\/\/doi.org\/10.1097\/AOG.0000000000003421","journal-title":"Obstet Gynecol"},{"key":"3244_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2019.09.002","author":"A Cheng","year":"2019","unstructured":"Cheng A, Li L, Wu M, Lang J (2019) Pathological findings following risk-reducing salpingo-oophorectomy in BRCA mutation carriers: a systematic review and meta-analysis. Eur J Surg Oncol. https:\/\/doi.org\/10.1016\/j.ejso.2019.09.002","journal-title":"Eur J Surg Oncol"},{"key":"3244_CR56","doi-asserted-by":"publisher","first-page":"180","DOI":"10.2478\/raon-2020-0020","volume":"54","author":"A Gornjec","year":"2020","unstructured":"Gornjec A, Merlo S, Novakovic S et al (2020) The prevalence of occult ovarian cancer in the series of 155 consequently operated high risk asymptomatic patients \u2014 Slovenian population based study. Radiol Oncol 54:180\u2013186. https:\/\/doi.org\/10.2478\/raon-2020-0020","journal-title":"Radiol Oncol"},{"key":"3244_CR57","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.ygyno.2020.02.006","volume":"157","author":"SK Rush","year":"2020","unstructured":"Rush SK, Swisher EM, Garcia RL et al (2020) Pathologic findings and clinical outcomes in women undergoing risk-reducing surgery to prevent ovarian and fallopian tube carcinoma: a large prospective single institution experience. Gynecol Oncol 157:514\u2013520. https:\/\/doi.org\/10.1016\/j.ygyno.2020.02.006","journal-title":"Gynecol Oncol"},{"key":"3244_CR58","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3121\/cmr.2007.702","volume":"5","author":"CP Crum","year":"2007","unstructured":"Crum CP, Drapkin R, Kindelberger D et al (2007) Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer. Clin Med Res 5:35\u201344","journal-title":"Clin Med Res"},{"key":"3244_CR59","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4132\/jptm.2016.06.17","volume":"52","author":"N Koc","year":"2018","unstructured":"Koc N, Ayas S, Arinkan SA (2018) Comparison of the classical method and SEE-FIM protocol in detecting microscopic lesions in fallopian tubes with gynecological lesions. J Pathol Transl Med 52:21\u201327. https:\/\/doi.org\/10.4132\/jptm.2016.06.17","journal-title":"J Pathol Transl Med"},{"issue":"Suppl 1","key":"3244_CR60","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1097\/PGP.0000000000000552","volume":"38","author":"A Malpica","year":"2019","unstructured":"Malpica A, Euscher ED, Hecht JL et al (2019) Endometrial carcinoma, grossing and processing issues: recommendations of the International Society of Gynecologic Pathologists. Int J Gynecol Pathol 38(Suppl 1):S9\u2013S24. https:\/\/doi.org\/10.1097\/PGP.0000000000000552","journal-title":"Int J Gynecol Pathol"},{"key":"3244_CR61","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/PGP.0b013e3181c713a8","volume":"29","author":"JW Carlson","year":"2010","unstructured":"Carlson JW, Jarboe EA, Kindelberger D et al (2010) Serous tubal intraepithelial carcinoma: diagnostic reproducibility and its implications. Int J Gynecol Pathol 29:310\u2013314. https:\/\/doi.org\/10.1097\/PGP.0b013e3181c713a8","journal-title":"Int J Gynecol Pathol"},{"key":"3244_CR62","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1097\/PAS.0b013e31822f58bc","volume":"35","author":"K Visvanathan","year":"2011","unstructured":"Visvanathan K, Vang R, Shaw P et al (2011) Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features. Am J Surg Pathol 35:1766\u20131775. https:\/\/doi.org\/10.1097\/PAS.0b013e31822f58bc","journal-title":"Am J Surg Pathol"},{"key":"3244_CR63","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1001\/jama.2017.14585","volume":"318","author":"BE Bejnordi","year":"2017","unstructured":"Bejnordi BE, Veta M, Van Diest PJ et al (2017) Diagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with breast cancer. JAMA - J Am Med Assoc 318:2199\u20132210. https:\/\/doi.org\/10.1001\/jama.2017.14585","journal-title":"JAMA - J Am Med Assoc"},{"key":"3244_CR64","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S1470-2045(19)30739-9","volume":"21","author":"W Bulten","year":"2020","unstructured":"Bulten W, Pinckaers H, van Boven H et al (2020) Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study. Lancet Oncol 21:233\u2013241. https:\/\/doi.org\/10.1016\/S1470-2045(19)30739-9","journal-title":"Lancet Oncol"},{"key":"3244_CR65","unstructured":"van der Valk P (2019) Specialisatie versus generalisme in de pathologie. Ned Tijdschr Geneeskd 163"},{"key":"3244_CR66","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1136\/jclinpath-2020-206991","volume":"74","author":"M Varma","year":"2021","unstructured":"Varma M, McCluggage WG, Shah V, Berney DM (2021) Pathologists can get it right the first time. J Clin Pathol 74:271\u2013272","journal-title":"J Clin Pathol"},{"key":"3244_CR67","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/modpathol.2016.238","volume":"30","author":"EEK Meserve","year":"2017","unstructured":"Meserve EEK, Brouwer J, Crum CP (2017) Serous tubal intraepithelial neoplasia: the concept and its application. Mod Pathol 30:710\u2013721. https:\/\/doi.org\/10.1038\/modpathol.2016.238","journal-title":"Mod Pathol"},{"key":"3244_CR68","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/PGP.0000000000000604","volume":"39","author":"ME Perrone","year":"2020","unstructured":"Perrone ME, Reder NP, Agoff SN et al (2020) An alternate diagnostic algorithm for the diagnosis of intraepithelial fallopian tube lesions. Int J Gynecol Pathol 39:261\u2013269. https:\/\/doi.org\/10.1097\/PGP.0000000000000604","journal-title":"Int J Gynecol Pathol"},{"key":"3244_CR69","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/PGP.0b013e31823b8831","volume":"31","author":"R Vang","year":"2012","unstructured":"Vang R, Visvanathan K, Gross A et al (2012) Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma. Int J Gynecol Pathol 31:243\u2013253. https:\/\/doi.org\/10.1097\/PGP.0b013e31823b8831","journal-title":"Int J Gynecol Pathol"},{"key":"3244_CR70","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/35042675","volume":"408","author":"B Vogelstein","year":"2000","unstructured":"Vogelstein B, Lane D, Levine AJ (2000) Surfing the p53 network. Nature 408:307\u2013310. https:\/\/doi.org\/10.1038\/35042675","journal-title":"Nature"},{"key":"3244_CR71","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/path.2696","volume":"221","author":"AA Ahmed","year":"2010","unstructured":"Ahmed AA, Etemadmoghadam D, Temple J et al (2010) Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary. J Pathol 221:49\u201356. https:\/\/doi.org\/10.1002\/path.2696","journal-title":"J Pathol"},{"key":"3244_CR72","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/cjp2.53","volume":"2","author":"M K\u00f6bel","year":"2016","unstructured":"K\u00f6bel M, Piskorz AM, Lee S et al (2016) Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma. J Pathol Clin Res 2:247\u2013258. https:\/\/doi.org\/10.1002\/cjp2.53","journal-title":"J Pathol Clin Res"},{"key":"3244_CR73","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1093\/jnci\/djt306","volume":"105","author":"MYC Polley","year":"2013","unstructured":"Polley MYC, Leung SCY, McShane LM et al (2013) An international ki67 reproducibility study. J Natl Cancer Inst 105:1897\u20131906. https:\/\/doi.org\/10.1093\/jnci\/djt306","journal-title":"J Natl Cancer Inst"},{"key":"3244_CR74","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. Br Med J 327:557\u2013560","journal-title":"Br Med J"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-021-03244-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-021-03244-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-021-03244-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T21:06:31Z","timestamp":1650575191000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-021-03244-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["3244"],"URL":"https:\/\/doi.org\/10.1007\/s00428-021-03244-w","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,1]]},"assertion":[{"value":"16 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}